MISSED OUT ON THE LATEST CLINICAL GUIDELINE ANNOUNCEMENTS?

No problem, we’ve got you covered! Here’s a list to all guidelines and FDA approvals that were published last month. 


CLINICAL GUIDELINES

AAP

AGA

AHA

APA

ASCO

ASCRS

CDC

ITAC

NAMS

NHF

SITC

VA/DoD

WHO


EXCLUSIVE SOCIETY GUIDELINES AND MANY MORE!

Search, bookmark, add notes and create your personal clinical guideline library with your digital copy or one of our society and specialty subscription bundles.   


FDA APPROVALS

JULY 8, 2022       KRYSTEXXA & METHOTREXATE
To lower serum uric acid levels (sUA) in patients with chronic gout

­JULY 12, 2022      BLUDIGO
For Cystoscopic Assessment of the Ureters Following Urological and Gynecological Surgical Procedures

JULY 14, 2022      XALKROI
For adult and pediatric patients 1 year of age and older with unresectable, recurrent, or refractory inflammatory anaplastic lymphoma kinase (ALK)-positive myofibroblastic tumors (IMT)

­JULY 18, 2022      ZONISADE
Treatment of Partial-Onset Seizures

JULY 19, 2022      OPZELURA
Treatment of nonsegmental vitiligo in patients aged 12 years or older

JULY 27, 2022      BENLYSTA
For the treatment of adults and children aged 5 to 17 with active lupus nephritis (LN) who are receiving standard therapy. Lupus nephritis is a serious inflammation of the kidneys caused by lupus, which can lead to end-stage kidney disease, requiring dialysis or a kidney transplant

­JULY 29, 2022      ZORYVE
Treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older


Copyright © 2022 Guideline Central, All rights reserved.